Pinnacle Biologics Report issue

Contributed to NME For profit Phase 1 Phase 2
Founded: Deerfield IL United States (2007)
Status: Acquired by Advanz Pharma (2013)

Organization Overview

First Clinical Trial
2013
NCT01682746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

PINNACLE BIOLGS | Pinnacle Biologics Inc.

Active Ingredients

Marketed Drugs (1)

porfimer (photofrin) (1995)

Drugs in Phase 2 Trials (1)

porfimer (photofrin) (4 trials)

Drugs in Phase 1 Trials (2)

gemcitabine (gemzar) (1 trial)

methylene blue (proveblue) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Brain Neoplasms (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Acinar Cell (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Glioma (Phase 2)

Lung Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 1)

Small Cell Lung Carcinoma (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3